Stock Events

Stock Events

ARS Pharmaceuticals (SPRY) Q2 2026 Earnings

May 15Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.61

-0.52

-0.43

-0.34

Details

Expected EPS

-0.516

Actual EPS

-0.61

Surprise EPS

-0.09

Surprise Percent

-18.22%

Description

⁨ARS Pharmaceuticals⁩ (⁦SPRY⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.